Terms: = Brain cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439
56 results:
1. MediMer: a versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection.
Meyer M; Parpoulas C; Barthélémy T; Becker JP; Charoentong P; Lyu Y; Börsig S; Bulbuc N; Tessmer C; Weinacht L; Ibberson D; Schmidt P; Pipkorn R; Eichmüller SB; Steinberger P; Lindner K; Poschke I; Platten M; Fröhling S; Riemer AB; Hassel JC; Roberti MP; Jäger D; Zörnig I; Momburg F
Front Immunol; 2023; 14():1294565. PubMed ID: 38239352
[TBL] [Abstract] [Full Text] [Related]
2. Over-representation analysis of angiogenic factors in immunosuppressive mechanisms in neoplasms and neurological conditions during COVID-19.
Chatterjee S; Sanjeev BS
Microb Pathog; 2023 Dec; 185():106386. PubMed ID: 37865274
[TBL] [Abstract] [Full Text] [Related]
3. Society for Immunotherapy of cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.
Pavlick AC; Ariyan CE; Buchbinder EI; Davar D; Gibney GT; Hamid O; Hieken TJ; Izar B; Johnson DB; Kulkarni RP; Luke JJ; Mitchell TC; Mooradian MJ; Rubin KM; Salama AK; Shirai K; Taube JM; Tawbi HA; Tolley JK; Valdueza C; Weiss SA; Wong MK; Sullivan RJ
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37852736
[TBL] [Abstract] [Full Text] [Related]
4. NLGN4X TCR transgenic T cells to treat gliomas.
Krämer C; Kilian M; Chih YC; Kourtesakis A; Hoffmann DC; Boschert T; Koopmann P; Sanghvi K; De Roia A; Jung S; Jähne K; Day B; Shultz LD; Ratliff M; Harbottle R; Green EW; Will R; Wick W; Platten M; Bunse L
Neuro Oncol; 2024 Feb; 26(2):266-278. PubMed ID: 37715782
[TBL] [Abstract] [Full Text] [Related]
5. ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.
Mota I; Patrucco E; Mastini C; Mahadevan NR; Thai TC; Bergaggio E; Cheong TC; Leonardi G; Karaca-Atabay E; Campisi M; Poggio T; Menotti M; Ambrogio C; Longo DL; Klaeger S; Keshishian H; Sztupinszki ZM; Szallasi Z; Keskin DB; Duke-Cohan JS; Reinhold B; Carr SA; Wu CJ; Moynihan KD; Irvine DJ; Barbie DA; Reinherz EL; Voena C; Awad MM; Blasco RB; Chiarle R
Nat Cancer; 2023 Jul; 4(7):1016-1035. PubMed ID: 37430060
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma.
Takei J; Kamata Y; Tanaka T; Fukasawa N; Gomisawa K; Satake M; Mori R; Yamamoto Y; Suzuki T; Oda A; Murahashi M; Fukuda T; Shimoda M; Murayama Y; Akasaki Y
Cancer Immunol Immunother; 2023 Oct; 72(10):3175-3189. PubMed ID: 37382632
[TBL] [Abstract] [Full Text] [Related]
7. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Garcia-Recio S; Hinoue T; Wheeler GL; Kelly BJ; Garrido-Castro AC; Pascual T; De Cubas AA; Xia Y; Felsheim BM; McClure MB; Rajkovic A; Karaesmen E; Smith MA; Fan C; Ericsson PIG; Sanders ME; Creighton CJ; Bowen J; Leraas K; Burns RT; Coppens S; Wheless A; Rezk S; Garrett AL; Parker JS; Foy KK; Shen H; Park BH; Krop I; Anders C; Gastier-Foster J; Rimawi MF; Nanda R; Lin NU; Isaacs C; Marcom PK; Storniolo AM; Couch FJ; Chandran U; Davis M; Silverstein J; Ropelewski A; Liu MC; Hilsenbeck SG; Norton L; Richardson AL; Symmans WF; Wolff AC; Davidson NE; Carey LA; Lee AV; Balko JM; Hoadley KA; Laird PW; Mardis ER; King TA; ; Perou CM
Nat Cancer; 2023 Jan; 4(1):128-147. PubMed ID: 36585450
[TBL] [Abstract] [Full Text] [Related]
8. [Preclinical study of T cell receptor specifically reactive with
Cheng XJ; Jiang D; Zhang LH; Wang JH; Li YZ; Zhai JH; Yan BQ; Zhang LL; Xie XW; Li ZY; Ji JF
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):884-895. PubMed ID: 36241231
[TBL] [Abstract] [Full Text] [Related]
9. Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma.
Lorenzo-Herrero S; Sordo-Bahamonde C; Martínez-Pérez A; Corte-Torres MD; Fernández-Vega I; Solís-Hernández MP; González S
Cancer Sci; 2023 Jan; 114(1):48-62. PubMed ID: 36082628
[TBL] [Abstract] [Full Text] [Related]
10. The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma.
Herremans KM; Szymkiewicz DD; Riner AN; Bohan RP; Tushoski GW; Davidson AM; Lou X; Leong MC; Dean BD; Gerber M; Underwood PW; Han S; Hughes SJ
Neoplasia; 2022 Jun; 28():100789. PubMed ID: 35395492
[TBL] [Abstract] [Full Text] [Related]
11. Insignificant effects of loss of heterozygosity in HLA in the efficacy of immune checkpoint blockade treatment.
Yang Y; Kim E; Kim S
Genes Genomics; 2022 Apr; 44(4):509-515. PubMed ID: 35107815
[TBL] [Abstract] [Full Text] [Related]
12. A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies.
Fu S; Piccioni DE; Liu H; Lukas RV; Kesari S; Aregawi D; Hong DS; Yamaguchi K; Whicher K; Zhang Y; Chen YL; Poola N; Eddy J; Blum D
Sci Rep; 2021 Nov; 11(1):22355. PubMed ID: 34785698
[TBL] [Abstract] [Full Text] [Related]
13. Integrative Analysis to Identify Genes Associated with Stemness and Immune Infiltration in Glioblastoma.
Warrier NM; Agarwal P; Kumar P
Cells; 2021 Oct; 10(10):. PubMed ID: 34685742
[TBL] [Abstract] [Full Text] [Related]
14. The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study.
Ita MI; Wang JH; Toulouse A; Lim C; Fanning N; O'Sullivan M; Nolan Y; Kaar GF; Redmond HP
Acta Neurochir (Wien); 2022 Mar; 164(3):723-735. PubMed ID: 34643804
[TBL] [Abstract] [Full Text] [Related]
15. Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma.
Mueller S; Taitt JM; Villanueva-Meyer JE; Bonner ER; Nejo T; Lulla RR; Goldman S; Banerjee A; Chi SN; Whipple NS; Crawford JR; Gauvain K; Nazemi KJ; Watchmaker PB; Almeida ND; Okada K; Salazar AM; Gilbert RD; Nazarian J; Molinaro AM; Butterfield LH; Prados MD; Okada H
J Clin Invest; 2020 Dec; 130(12):6325-6337. PubMed ID: 32817593
[TBL] [Abstract] [Full Text] [Related]
16. Noncoplanar VMAT for brain Metastases: A Plan Quality and Delivery Efficiency Comparison With Coplanar VMAT, IMRT, and CyberKnife.
Zhang S; Yang R; Shi C; Li J; Zhuang H; Tian S; Wang J
Technol Cancer Res Treat; 2019 Jan; 18():1533033819871621. PubMed ID: 31451059
[TBL] [Abstract] [Full Text] [Related]
17. Clinical Characteristics and Postoperative Recovery of Hypopituitarism in Patients with Nonfunctional Pituitary Adenoma.
Zhang R; Wang Z; Gao L; Guo X; Feng C; Deng K; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
World Neurosurg; 2019 Jun; 126():e1183-e1189. PubMed ID: 30880207
[TBL] [Abstract] [Full Text] [Related]
18. A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.
Tsuboi A; Hashimoto N; Fujiki F; Morimoto S; Kagawa N; Nakajima H; Hosen N; Nishida S; Nakata J; Morita S; Sakamoto J; Oji Y; Oka Y; Sugiyama H
Cancer Immunol Immunother; 2019 Feb; 68(2):331-340. PubMed ID: 30430205
[TBL] [Abstract] [Full Text] [Related]
19. SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4
Lacher MD; Bauer G; Fury B; Graeve S; Fledderman EL; Petrie TD; Coleal-Bergum DP; Hackett T; Perotti NH; Kong YY; Kwok WW; Wagner JP; Wiseman CL; Williams WV
Front Immunol; 2018; 9():776. PubMed ID: 29867922
[TBL] [Abstract] [Full Text] [Related]
20. Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma.
Orlando D; Miele E; De Angelis B; Guercio M; Boffa I; Sinibaldi M; Po A; Caruana I; Abballe L; Carai A; Caruso S; Camera A; Moseley A; Hagedoorn RS; Heemskerk MHM; Giangaspero F; Mastronuzzi A; Ferretti E; Locatelli F; Quintarelli C
Cancer Res; 2018 Jun; 78(12):3337-3349. PubMed ID: 29615432
[TBL] [Abstract] [Full Text] [Related]
[Next]
